Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dagmar, Smitalova"'
Publikováno v:
Practical Laboratory Medicine, Vol 25, Iss , Pp e00210- (2021)
BCR-ABL1 molecular detection using quantitative PCR (qPCR) methods is the golden standard of chronic myeloid leukemia (CML) monitoring. However, due to variable sensitivity of qPCR assays across laboratories, alternative methods are tested. Digital P
Externí odkaz:
https://doaj.org/article/b9147eff25494ab38b272b3f709e80ff
Publikováno v:
Practical Laboratory Medicine, Vol 25, Iss, Pp e00210-(2021)
BCR-ABL1 molecular detection using quantitative PCR (qPCR) methods is the golden standard of chronic myeloid leukemia (CML) monitoring. However, due to variable sensitivity of qPCR assays across laboratories, alternative methods are tested. Digital P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dae57936234e0660709a507bd7c3e1b
http://www.sciencedirect.com/science/article/pii/S235255172100010X
http://www.sciencedirect.com/science/article/pii/S235255172100010X
Publikováno v:
Practical Laboratory Medicine
BCR-ABL1 molecular detection using quantitative PCR (qPCR) methods is the golden standard of chronic myeloid leukemia (CML) monitoring. However, due to variable sensitivity of qPCR assays across laboratories, alternative methods are tested. Digital P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::57a22ce4b104ddeb288f5115cd30692a
https://pubmed.ncbi.nlm.nih.gov/33778144
https://pubmed.ncbi.nlm.nih.gov/33778144
Publikováno v:
Blood. 134:2922-2922
Introduction: Detection of leukemic stem cells (LSCs) may represent a new potential prognostic parameter in chronic myeloid leukemia (CML) and a tool for minimal residual disease monitoring in combination with standard qPCR method. To date CD26 is st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3be9c36b1d1a76d71c4940c52b87971f
https://doi.org/10.1182/blood-2019-127809
https://doi.org/10.1182/blood-2019-127809
Publikováno v:
Blood. 134:2920-2920
BACKGROUND: Bcr-abl1 oncogene targeted treatment with tyrosine kinase inhibitors (TKI) showed an impressive efficacy against proliferating chronic myeloid leukemia (CML) cells. However, rapid relapses in more than half of CML patients after discontin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c43a9dbc4b7246859c78d784c62991b4
https://doi.org/10.1182/blood-2019-126924
https://doi.org/10.1182/blood-2019-126924
Autor:
Vitezsla Kolek, Martin Petrek, Amit Kishore, Dagmar Smitalova, Eva Novosadova, Zdenka Navratilova
Publikováno v:
1.5 Diffuse Parenchymal Lung Disease.
Introduction: Pulmonary sarcoidosis is an inflammatory granulomatous disease with the deregulated expression profile of intracellular miRNAs. There has been however the limited information on exosomal miRNAs in sarcoidosis and no data on either bronc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7ac38905db7af538a94407c6aad1147
https://doi.org/10.1183/13993003.congress-2015.pa3319
https://doi.org/10.1183/13993003.congress-2015.pa3319